L
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Price:
4.57
CNY
1.33%
Market Closed
Market Cap:
¥3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
CN |
|
W
|
Walt Disney Co
SWB:WDP
|
US |
|
A
|
AURELIUS Equity Opportunities SE & Co KgaA
XETRA:AR4
|
DE |
|
Amara Raja Energy & Mobility Ltd
BSE:500008
|
IN |
|
Galaxy Entertainment Group Ltd
OTC:GXYEF
|
HK |
|
Krung Thai Bank PCL
SET:KTB
|
TH |
|
Prosafe SE
OSE:PRS
|
NO |
Multiples-Based Value
The Multiples-Based Value of one Lionco Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 4.57 CNY, Lionco Pharmaceutical Group Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Lionco Pharmaceutical Group Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Lionco Pharmaceutical Group Co Ltd Competitors
Lionco Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
3.3B CNY | 7.7 | -27.8 | -42.3 | -42.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.5 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.1 | 7.5 | 8.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
